Chief Medical Officer at COTA, Inc.
Real-World Data Offers Significant Opportunities for Developing New Therapies for Hematologic Cancers
By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.